Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7995660796c354a2881371a7406bf6dd |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-101 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0819 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
filingDate |
2011-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32125f46ecd00c7dce4e8d6327fb9b28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18a63505d49a3f58ecc8381181ec1f05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e05873d94eb46ac83ac95028f8818a5 |
publicationDate |
2011-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2011140526-A |
titleOfInvention |
Peptide product |
abstract |
Useful peptide products are provided. A crystalline salt of a peptide Gly-Gly-Val-Leu-Val-Gln-Pro-Gly (SEQ ID NO: 1), wherein the salt of the peptide is selected from hydrochloride or acetate; The crystalline salt wherein the salt of the peptide is acetate; the crystalline salt wherein the acetate salt is present at a concentration of less than 50 mol% / mol of the peptide; the crystalline salt wherein the salt of the peptide is the hydrochloride salt; The crystalline salt, wherein the hydrochloride salt has a purity of at least 98.5% by HPLC; the peptide Gly-Gly-Val-Leu-Val-Gln-Pro-Gly (SEQ ID NO: having a purity of at least 98.5% by HPLC Isolated hydrochloride of 1). [Selection figure] None |
priorityDate |
2007-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |